Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
EPI-001: Translational Breakthroughs with AR NTD Inhibition
2026-05-22
This article explores the mechanistic and translational significance of EPI-001, an androgen receptor N-terminal domain inhibitor, for advanced prostate and triple-negative breast cancer research. Drawing from recent studies and competitive insights, it offers actionable guidance for researchers leveraging EPI-001 to confront resistance mechanisms and interrogate AR-driven oncogenic signaling.
-
Murine RNase Inhibitor: Optimizing RNA Degradation Preventio
2026-05-22
Murine RNase Inhibitor delivers oxidation-resistant RNA protection that outperforms conventional RNase A inhibitors, especially in workflows sensitive to low reducing conditions. See how this APExBIO product streamlines cgSHAPE-seq, real-time RT-PCR, and cDNA synthesis, with tips for troubleshooting and maximizing assay reliability.
-
Efficient RGC Differentiation via Dual SMAD and Wnt Inhibiti
2026-05-21
The referenced study establishes a reproducible, chemically defined protocol using dual SMAD and Wnt inhibition to efficiently differentiate human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) with high purity. This advancement addresses variability and yield issues in RGC derivation, supporting more reliable models for glaucoma and neurodegenerative disease research.
-
Functional Constraints of Influenza A NEP Revealed by Deep M
2026-05-21
This study systematically maps the mutational tolerance and functional constraints of the influenza A virus nuclear export protein (NEP) using deep mutational scanning. By analyzing over 1,800 single amino acid variants, the research uncovers distinct roles for NEP domains and reveals mechanisms relevant for viral adaptation and RNA synthesis regulation.
-
Rotigotine Hydrochloride: Neuroprotection and LUTS Modulatio
2026-05-20
Discover how Rotigotine hydrochloride, a dopamine D2/D3 receptor agonist, advances Parkinson’s disease research through its dual neuroprotective and lower urinary tract effects. This article provides novel insight into translational preclinical modeling and practical assay optimization.
-
AZD2461: Setting a New Standard for PARP Inhibitor Assay Pre
2026-05-20
Discover how AZD2461, a novel PARP inhibitor, advances breast cancer research with precise, real-time insights into DNA repair and drug response. This article uniquely explores assay design and interpretation, bridging mechanistic depth with practical workflow guidance.
-
PP 2 (AG 1879): Applied Src Kinase Inhibition in Cell Signal
2026-05-19
PP 2 (AG 1879) empowers researchers to dissect Src-mediated pathways with nanomolar precision, enabling robust investigation of cancer, immunity, and cytoskeletal signaling. This guide connects advanced use-cases, stepwise protocols, and troubleshooting strategies to maximize reproducibility and insight with this trusted APExBIO inhibitor.
-
Indomethacin: Applied Experimental Workflows in Inflammation
2026-05-19
Indomethacin, a Cox-1 selective nonsteroidal anti-inflammatory drug, empowers precise modulation of inflammatory and metabolic pathways in cell and membrane studies. This article delivers actionable workflow enhancements, troubleshooting strategies, and novel applications, integrating the latest insights from renal injury models and mechanistic research.
-
Filipin III (SKU B6034): Reliable Cholesterol Detection in M
2026-05-18
This article addresses real-world challenges in membrane cholesterol visualization and assay reproducibility, highlighting how Filipin III (SKU B6034) from APExBIO supports robust, quantitative workflows. Scenario-driven Q&A blocks guide researchers through experimental design, protocol optimization, and vendor selection, grounded in current literature and best practices.
-
Pam3CSK4 TFA: Decoding TLR1/2 Agonist Precision in Cytokine
2026-05-18
Explore how Pam3CSK4 TFA, a leading TLR1/2 agonist, enables precise and translationally relevant cytokine profiling in innate immunity research. Distinct from prior reviews, this article delivers a rigorous protocol-centric perspective and actionable assay decision insights.
-
Super-Enhancer-Driven LINC01977 and TGF-β/Smad3 in Early LUA
2026-05-17
Zhang et al. (2022) identified super-enhancer hijacking of LINC01977 as a key driver of malignancy in early-stage lung adenocarcinoma via the canonical TGF-β/SMAD3 pathway. These findings reveal a novel epigenetic mechanism underlying tumor progression and highlight potential molecular targets for future therapeutic development.
-
Biotin-tyramide: Enzyme-Mediated Signal Amplification for IH
2026-05-16
Biotin-tyramide unlocks ultrasensitive detection in tissue and cell-based assays by leveraging HRP-catalyzed tyramide signal amplification. This guide translates bench-proven workflows and key research findings into actionable protocols, troubleshooting strategies, and advanced applications, helping researchers achieve robust, reproducible results in immunohistochemistry and in situ hybridization.
-
Targeting AR and ARv7 in TNBC: Insights on EPI-001 Efficacy
2026-05-15
This study elucidates the prognostic significance of androgen receptor (AR) and its splice variant ARv7 in triple-negative breast cancer (TNBC), linking their expression to poor patient outcomes and increased metastasis. Using AR N-terminal domain inhibitors like EPI-001, the research demonstrates modulation of metastasis and EMT markers, suggesting new avenues for AR-driven TNBC intervention.
-
Geneticin, G-418 Sulfate: Precision Selection & Antiviral In
2026-05-15
Explore the molecular mechanisms and advanced applications of Geneticin (G-418 Sulfate) as both a powerful selection antibiotic and antiviral research tool. This in-depth analysis reveals how G418 Sulfate informs assay design, drawing on the latest research to empower genetic engineering and virology labs.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Precision in Mouse I
2026-05-14
Harness the Cy3 Goat Anti-Mouse IgG (H+L) Antibody for ultrasensitive mouse IgG detection across immunofluorescence, flow cytometry, and western blotting. Discover robust protocol optimizations, advanced troubleshooting, and actionable insights derived from the latest biomarker research and expert workflow guides.